Your browser doesn't support javascript.
loading
Efficacy and Safety of Dapagliflozin According to Background Use of Cardiovascular Medications in Patients With Type 2 Diabetes: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
Oyama, Kazuma; Raz, Itamar; Cahn, Avivit; Goodrich, Erica L; Bhatt, Deepak L; Leiter, Lawrence A; McGuire, Darren K; Wilding, John P H; Gause-Nilsson, Ingrid A M; Mosenzon, Ofri; Sabatine, Marc S; Wiviott, Stephen D.
Afiliación
  • Oyama K; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Raz I; Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Cahn A; Diabetes Unit, Department of Endocrinology and Metabolism, Hadassah Medical Center, Jerusalem, Israel.
  • Goodrich EL; Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Bhatt DL; Diabetes Unit, Department of Endocrinology and Metabolism, Hadassah Medical Center, Jerusalem, Israel.
  • Leiter LA; Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
  • McGuire DK; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Wilding JPH; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Gause-Nilsson IAM; Li Ka Shing Knowledge Institute, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.
  • Mosenzon O; Division of Cardiology, University of Texas Southwestern Medical Center, Parkland Health and Hospital System, Dallas.
  • Sabatine MS; Department of Cardiovascular and Metabolic Medicine, University of Liverpool, Liverpool, United Kingdom.
  • Wiviott SD; BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
JAMA Cardiol ; 7(9): 914-923, 2022 09 01.
Article en En | MEDLINE | ID: mdl-35857296
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_cardiovascular_diseases / 6_diabetes / 6_endocrine_disorders / 6_other_circulatory_diseases Asunto principal: Fármacos Cardiovasculares / Diabetes Mellitus Tipo 2 / Insuficiencia Cardíaca Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: JAMA Cardiol Año: 2022 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_cardiovascular_diseases / 6_diabetes / 6_endocrine_disorders / 6_other_circulatory_diseases Asunto principal: Fármacos Cardiovasculares / Diabetes Mellitus Tipo 2 / Insuficiencia Cardíaca Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: JAMA Cardiol Año: 2022 Tipo del documento: Article